Skip to main content
. 2022 Jun 14;36(9):2151–2164. doi: 10.1038/s41375-022-01618-w

Fig. 2. Potential clinical applications and perspectives for translational research of ctDNA in B-cell lymphomas.

Fig. 2

Profiling of ctDNA might be performed at various disease landmarks at diagnosis, during treatment, during surveillance, and at lymphoma progression to support decision-making by physicians or contribute novel insights to address innovative translational research questions. CNS central nervous system, MRD minimal residual disease.